Renal injury is greater in male compared to female rats after renal wrap (RW) hypertension. We investigated the role of gonadal steroids in the sex differences in RW disease severity in male (M) and female (F), castrated (Cast) and ovariectomized (OVX) rats and after dihydrotestosterone (DHT) and 17ß-estradiol (E 2 
Introduction
As early as 1846, Richard Bright noted that patients with renal disease develop hypertension (7) and in 1923, Franz Vohard recognized the "vicious circle" in postulating hypertension causes renal insufficiency (33) . Direct evidence of hypertension causing renal disease arises from studies in patients with glomerulonephritis (28) and diabetic nephropathy (9) in which a genetic predisposition to hypertension increases the risk of developing renal disease and from clinical trials showing that antihypertensive treatments slow the progression of renal disease (17) .
We have recently shown that renal pathology develops in the 1-kidney, figure 8 renal wrap (RW) model of experimental hypertension and that male rats exhibited a greater degree of renal damage than the females nine weeks after RW surgery despite similar degrees of hypertension and renal function (15) . Markers of renal injury including proteinuria, mean glomerular volume (MGV), glomerulosclerosis (GS) and tubular damage were greater in RW males compared to RW females while mean arterial pressures (MAP) and glomerular filtration rates (GFR) were not detectably different between the sexes. These data suggested that the sex of the animal is an independent factor contributing to the degree of renal disease progression in RW hypertension.
These sex differences in renal disease severity reflect clinical studies indicating that the progression of renal disease is more rapid in men compared to women. Men exhibit a faster decline in renal function compared to women in non-diabetic renal disease, polycystic kidney disease, membranous nephropathy, and IgA nephropathy (19) . In this study, we determined the role of gonadal steroids in renal disease severity in RW hypertension. We investigated the effect of male castration and female ovariectomy nine weeks after RW hypertension on MAP, GFR and parameters of renal injury including proteinuria, MGV, GSI and, tubular damage. We also determined the role of androgens and estrogens in renal disease progression by investigating the effects of DHT in castrated males as well as E 2 treatment in ovariectomized females. Lastly, we treated both Sham-OVX and RW-OVX rats with DHT to determine if androgens accelerate disease progression in females.
Experimental Procedures

Animal maintenance
Sprague Dawley female and male rats (7-8 weeks old) were purchased from Harlan (Madison, WI) and maintained on a phytoestrogen free normal salt diet (NS, 0.4% NaCl; Harlan) with free access to water.
Animal Surgeries, hormone treatment and Body Weights
Under isoflurane anesthesia, the testis was removed in the male castration group (Cast) and the ovaries were removed in the ovariectomized (OVX) group.
Administration of DHT (50 mg), E 2 (0.6 mg) or vehicle was accomplished by implanting 60-day release pellets (Innovative Research Inc., Sarasota, FL) subcutaneously in the dorsal region. For the control male (M) and female (F) groups, the testes or ovaries were visualized but not removed. In the RW animals, the right kidney was removed while the contralateral kidney was tied using 2.0 silk thread (RW-M, n=8; RW-Cast, n=10; RW-Cast+DHT, n=11; RW-F, n=8; RW-OVX, n=21; RW-OVX+E 2 , n=15; RW-OVX+DHT, n=10) whereas in sham controls (Sham-M, n=6; Sham-Cast, n=10; ShamCast+DHT, n=10; Sham-F, n=6; Sham-OVX, n=16; Sham-OVX+E 2 , n=12; Sham-OVX+DHT, n=6), both kidneys were visualized but not removed or wrapped (14) . Body weights were determined at 0, 3, 6 and 9 weeks post surgery.
Blood pressure measurements and blood sampling
Nine weeks after sham or RW surgeries, all rats were anesthetized with Inactin (100 mg/kg) (Sigma) and placed on a heated table to maintain body temperature at 37°C. A tracheotomy was performed to allow spontaneous breathing. A catheter was placed in the carotid artery for blood pressure measurements using a Blood Pressure Analyzer (Digi-Med, Inc., Louisville, KY) and for blood sampling. At time of sacrifice, blood was collected in ice-cold Vacutainer tubes (Becton Dickinson) containing heparin sulfate. Samples were centrifuged at 2,000 g for 10 minutes and the plasma (supernatant) was removed and frozen at -20˚ for hormone assays.
Steroid hormone levels
Plasma testosterone (T) and E 2 levels were determined by radioimmunoassay (Coat-A-Count total testosterone, Coat-A-Count E 2 , Diagnostic Products Corp., Los Angeles, CA). DHT was determined by ELISA (Alpha Diagnostics Int., San Antonio, TX).
Glomerular filtration rate (GFR)
Serum and urinary creatinine levels were measured with a creatinine autoanalyzer (Creatinine Analyzer 2, Beckmann Instruments) nine weeks after sham or RW surgeries in all animal groups. Creatinine clearance per 100 g body weight was calculated on the basis of 24 h urine collection. Plasma standards were run to ensure chromagen interference was minimal in these samples.
Urine protein excretion
Rats were placed in metabolic cages for determination of 24 h urinary protein excretion rates using the Bradford method (6).
Histology Preparation
After 9 weeks, rats were anesthetized with Inactin (100 mg/kg). Kidneys were fixed in 10% formaldehyde and embedded in 2-hydroxyethyl-methacrilate (Technovit 7100, Kulzer, Wehrheim, Germany) to minimize tissue distortion associated with paraffin embedding. Renal tissue was cut into 2 µm sections and stained with Hematoxylin and Eosin (for general morphological examination), Periodic acid Schiff's (PAS) (for assessment of basement membrane changes) or Masson's trichrome stain (for demonstration of collagen deposition). PAS-stained sections were examined using a Nikon Eclipse E600 light microscope.
Morphological Analysis
A custom-made, C language macro was written to measure the area of glomerular tuft profiles with the Optimas 6.5 image analysis system (Optimas Corp. by MediaCybernetics, Silver Spring, MD). The areas of at least 100 glomerular tuft profiles per kidney were measured. The glomerular tufts considered were subsequent unselected occurrences falling in the observation field of the operator who moved the stage in a serpentine fashion from the outer to the juxtamedullary cortex. The mean glomerular volume (MGV) was estimated from the harmonic mean of the profile areas as previously described (18) .
Renal Pathology
All specimens were examined by a pathologist (C.P.) blinded to the group assignment of the experimental animals. One hundred glomeruli per section were assessed and the degree of glomerular sclerosis was graded on a scale of 0 to 4 [Grade 0, (normal glomeruli); Grade 1, sclerotic area up to 1-25% (minimal sclerosis); Grade 2, sclerotic area 26-50% (moderate sclerosis); Grade 3, sclerotic area 51-75% (moderate-severe sclerosis); Grade 4, sclerotic area 76-100% (severe sclerosis)]. The glomerulosclerotic index (GSI) index was calculated using the following formula: GSI= (1xn 1 ) + (2xn 2 ) + (3xn 3 ) + (4xn 4 )/n 0 + n 1 + n 2 + n 3 + n 4 , where n x is the number of glomeruli in each grade of glomerulosclerosis (GS). The degree of diffuse GS and nodular GS were graded on a scale of "+" to "++++" ("-", (normal); "+", affected area less than 1-25%; "++", affected area 26-50%; "+++", affected area 51-75%; "++++", affected area 75-100%). The degree of tubulointerstitial fibrosis was defined as tubular atrophy or dilatation, deposition of ECM and interstitial cell proliferation, and was assessed in Masson's trichrome-stained sections. The degree of tubulointerstitial fibrosis was graded on a scale of "+" to "++++" ("-", (normal); "+", affected area less than 1-25%; "++", affected area 26-50%; "+++", affected area 51-75%; "++++", affected area 75-100%). The relative degree of tubulointerstitial fibrosis was determined by the degree of tubular atrophy or dilatation, deposition of ECM and interstitial cell proliferation, and was assessed in Masson's trichrome-stained sections.
Statistics
Data are expressed as means ± standard error of the mean (SEM). Statistical significance of the differences between groups were determined by two-way ANOVA, followed by Student-Newman-Keuls post-hoc tests. Differences were considered significant at p<0.05.
Results
Gonadal steroid levels
RW surgery had no significant effects on T and DHT levels in either male or female animal groups whereas RW consistently reduced E 2 levels in both males and females to varying extents (Table 1) . Male castration markedly decreased T and DHT levels by > 97% but had no effect on plasma E 2 levels. Ovariectomy markedly reduced estradiol levels by > 4-fold. The antibody used to measure T crossreacts with DHT by less than 4% and with estradiol by less than 0.02% (Diagnostic Products Corp.).
Accordingly, DHT treatment in castrated males and ovariectomized females did not have any significant effects on plasma T levels. In contrast, the antibody to DHT crossreacts with testosterone by 8.7% (Alpha Diagnostics, Int.) and thus DHT measurements can include some degree of testosterone. DHT treatment of castrated males and ovariectomized females markedly increased DHT levels by > 5-fold and were similar to peak physiological levels of estrogen (12) . E 2 -treatment of ovariectomized females increased estrogen levels by > 10-fold. Non-castrated males had at least 30-fold higher levels of testosterone than females while nonovariectomized females had at least 4-fold higher levels of plasma estrogen than males.
Mean arterial pressure (MAP)
Castration and ovariectomy had no effect on MAP in the sham animal groups; nor did DHT or E 2 treatment have any effect; no differences in MAP were observed
Sham-OVX+DHT animal groups ( Table 2) . As shown before (15) , RW significantly increased MAP in male and female animals by approximately 30 mm Hg. Male castration and female ovariectomy had no detectable effects on MAP in the RW animal groups; DHT or E 2 treatment were also without effect; no differences in the degree of hypertension were observed among RW-M, RW-Cast, RW-Cast+DHT, RW-F, RW-OVX, RW-OVX+E 2 and RW-OVX+DHT groups (Table 2) .
Body weight
Body weights (BW) were comparable within female (241 ± 2.4) and within male (276 ± 2.0) animal groups at the outset of the study; however, male rats weighed 15% and 48% more than the Sham-F group at the outset and end of the study, respectively (Table 2) . Although BW increased in both sexes during the course of the nine week experiment, there was no effect of RW on female or male BW as found previously (15) . Furthermore, castration and DHT treatment did not effect male BW; no differences in BW were observed among Sham-M, Sham-Cast, Sham-Cast+DHT, RW-M, RW-Cast and RW-Cast+DHT or between Sham-F and RW-F, Sham-OVX and RW-OVX, Sham-OVX+E 2 and RW-OVX+E 2 or Sham-OVX+DHT and RW-OVX+DHT animal groups. In contrast, ovariectomy increased BW; BW was 20% and 15% higher in Sham-OVX and RW-OVX compared to Sham-F or RW-F, respectively. This OVX-induced weight gain was prevented by E 2 treatment; no differences in BW were observed among Sham-F, Sham-OVX+E 2 , RW-F and RW-OVX+E 2 . DHT treatment also had no effect on the OVX-induced weight gain; no differences in BW were observed among Sham-OVX+DHT, Sham-OVX, RW-OVX and RW-OVX+DHT animal groups.
GFR
Castration and ovariectomy had no effect on GFR in the sham animal groups; nor did DHT or E 2 treatment have any effect; no differences in GFR were observed among Sham-M, Sham-Cast, Sham-Cast+DHT, Sham-F, Sham-OVX, Sham-OVX+E 2 and Sham-OVX+DHT animal groups (Table 2) . Although RW significantly decreased GFR by approximately 37 -40% in all male and female animals, as shown before (15), castration and ovariectomy had no significant effects on GFR in the RW animal groups;
DHT and E 2 treatment were also without effect; no significant differences in GFR were observed among RW-M, RW-Cast, RW-Cast+DHT, RW-F, RW-OVX, RW-OVX+E 2 and RW-OVX+DHT groups (Table 2) .
Proteinuria
As shown before (15) , RW surgery increased the degree of proteinuria in both male and female animal groups (Table 3) . By 6 weeks, proteinuria was significantly elevated in all male RW groups compared to the Sham males. In contrast, no significant differences in proteinuria were observed in female RW animals compared to Sham females. By 9 weeks, proteinuria had worsened further and was significantly elevated in both males and females compared to their corresponding Sham groups (Table 3) . At 9 weeks, proteinuria was 6.8-fold higher in RW-M compared to Sham-M and 7.7-fold higher in RW-F compared to Sham-F animals. Male castration attenuated the degree of proteinuria in the RW animals; proteinuria was 19% less in the RW-Cast compared to RW-M group. DHT treatment reversed this protective effect of castration; no significant differences in urine protein were observed between RW-Cast+DHT and RW-M. Proteinuria was 2.1-fold higher in the Sham-M compared to the Sham-F and 1.9-fold higher in the RW-M compared to RW-F group. Ovariectomy and E 2 treatment had no effect on the degree of proteinuria; no differences in urine protein were observed (Table 3) . As shown before (15) , RW surgery increased the MGV in both the male and female animal groups; MGV was 2.2-fold higher in RW-M compared to Sham-M and 1.3-fold higher in RW-F compared to Sham-F rats. Male castration reduced the MGV in the RW animals; the MGV was 24% less in the RW-Cast compared to RW-M. DHT treatment reversed this effect; no significant differences in MGV were observed between RW-Cast+DHT and RW-M. Sex differences in MGV were noted as before (15); MGV was 1.9-fold higher in the RW-M compared to RW-F animals. Ovariectomy increased MGV in the RW-OVX animals by 1.5-fold compared to RW-F. E 2 treatment prevented this increase; no significant differences in MGV were observed between RW-OVX+E 2 and RW-F. DHT treatment had no effect; no differences between RW-OVX+DHT and RW-OVX were found.
Renal pathology
Male castration attenuated the renal injury induced by RW whereas the degree of renal damage in the RW-Cast+DHT animals was indistinguishable from the RW-M group. Compared to all other groups (Figs. 1 & 2, Table 4 ), renal damage (assessed by GSI and the degree of tubular damage) was most severe in the RW-M (Fig. 1B, Table 4) and RW-Cast+DHT (Fig. 1F, Table 4 ) animals. Many glomeruli were enlarged and frequently showed PAS-positive deposits in the mesangium, mesangial expansion, and areas of segmental necrosis. There were proteinaceous deposits in Bowman's space; some glomerular tufts showed sinechiae and the capsule was associated with cellular proliferation. The tubules were dilated and there were hyaline casts in the distal tubules.
Ovariectomy exacerbated the renal pathology induced by RW in the female (Fig. 2D) . The degree of renal injury in the RW-OVX rats was similar to the RW-Cast group (Fig. 1D) whereas the injury observed in the RW-OVX+E 2 group (Fig. 2F) was indistinguishable from the RW-F animals (Fig. 2B) . Milder lesions were observed in the RW-F (Fig. 2B) and RW-OVX+E 2 (Fig. 2F ) groups compared to the RW-M (Fig. 1B) , RWCast+DHT (Fig. 1F) , RW-Cast (Fig. 1D ) and RW-OVX (Fig. 2D) animals. Focal mesangial deposits of PAS-positive material were found but no segmental necrosis and only occasional hyaline casts were observed in the tubules. DHT treatment in RW-OVX+DHT (Fig. 2H ) animals resulted in renal pathology that was similar to the RW-M (Fig. 1B) and RW-Cast+DHT (Fig. 1F ). No differences in glomerular and tubular morphology were observed among Sham-M (Fig. 1A) , Sham-Cast (Fig. 1C) , Sham-Cast+DHT (Fig. 1E ), Sham-F ( Fig. 2A) , Sham-OVX (Fig. 2C) , Sham-OVX+E 2 ( Fig. 2E) and Sham-OVX+DHT (Fig.   2G ) groups.
Discussion
In a previous study we showed that male rats exhibit a greater degree of renal injury nine weeks after RW hypertension compared to females despite similar levels of MAP and renal function (15) . Our current study extends these earlier findings by determining the role of gonadal steroids in the observed sex differences in susceptibility to renal damage induced by this experimental model of RW hypertension.
Male castration significantly attenuated the development of proteinuria and glomerular and tubular damage. The finding that DHT treatment of castrated males prevented these protective effects, suggests androgens contribute to the development of renal pathology and proteinuria in the RW hypertensive male. The exacerbating effects of androgens on renal injury in RW hypertension are similar to observations in other models of renal disease including the unilaterally nephrectomized rat (11), adriamycin-induced nephropathy (22) , and the spontaneously hypertensive rat (24) , suggesting that androgens exacerbation of renal injury is a common mechanism in many causes of chronic renal failure (CRF). The fact that no significant differences in body weight were detected among any of the male RW groups including RW-M, RW-Cast and RW-Cast+DHT, suggests that the potential anabolic effects of testosterone on protein intake made minimal contributions to the development of renal injury in this model. The finding that castration and DHT treatment had no significant effects on MAP and GFR suggest that testosterone levels are an independent factor in the degree of renal injury in the RW hypertensive male.
While male castration was protective, ovariectomy exacerbated the degree of glomerular and tubular damage in the RW hypertensive female. The fact that E 2 treatment of ovariectomized RW females prevented the aggravating effects of ovariectomy on renal pathology suggests that estrogens protect against the development of glomerular and tubular damage. These findings in the RW hypertensive female are similar to some experimental models of renal disease.
Ovariectomy aggravated the development of glomerulosclerosis in the rat remnant kidney (2). However, not all models of CRF show this same estrogen nephroprotective effect. Glomerular hypertrophy and glomerular injury were unchanged by ovariectomy and estrogen replacement in uninephrectomized female rats (18) and glomerulopathy induced by aging in the female Munich Wistar rat was not affected by the presence or absence of estrogen (4) . While in obese Zucker rats (10) and in Nagase analbuminemic rats (16) , administration of E 2 to ovariectomized females actually impaired renal function and led to profound GS. Taken together, these data indicate that estrogen protects or contributes to progressive renal disease depending upon the cause of CRF.
As expected, the OVX rats gained greater body weight than vehicle-treated intact or E 2 -treated OVX animals. These differences in body weight may have led to differences in nephron to body weight ratios, which may have contributed to the greater renal damage observed in vehicle-treated OVX rats compared to the E 2 replete animals. However, differences in nephron to body weight ratios are unlikely to be a major contributor to the nephroprotective effects of estrogen since mostly adipose tissue accumulates in the OVX animal rather than muscle mass. We chose not to clamp body weights in all animal groups over the nine-week period because reducing foot intake in the males and OVX animal groups would have conferred a greater confounding variable than the potential contribution of differences in nephron-body weight ratios. The finding that ovariectomy as well as E 2 and DHT treatments had no major effects on MAP and renal function suggest that gonadal steroids are independent factors contributing to renal injury in the RW hypertensive (27) .
In summary, we found that the sex steroids, DHT and E 2 , contribute to the sex differences observed in RW-induced renal injury. Male castration attenuated the severity of proteinuria and glomerular and tubular damage while DHT treatment prevented these protective effects of castration and aggravated the effects of renal injury in ovariectomized females. Ovariectomy exacerbated the severity of glomerular and tubular damage while E 2 treatment protected against this injury. Together, these studies indicate that the lack of estrogen and the presence of androgens are independent factors that contribute to renal damage in RW hypertension. Figure 2 
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